TY  - CHAP
M1  - Book, Section
TI  - Antiviral Agents
A1  - Jobst, Erin E.
A1  - Panus, Peter C.
A1  - Kruidering-Hall, Marieke
Y1  - 2020
N1  - 
T2  - Pharmacology for the Physical Therapist, 2e
AB  - CASE  STUDYF.M.  is  a  44-year-old  man  who  has  been  human  immunodeficiency  virus  (HIV)  positive  for  10  years.  On  his  most  recent  physician  visit,  he  was  hyperglycemic  and  dyslipidemic.  Although  his  weight  has  been  stable  over  the  past  several  years,  he  noted  that  his  legs  appear  thinner  and  his  waist  is  definitely  larger.  The  patient’s  antiretroviral  therapy  regimen  includes  two  nucleoside  reverse  transcriptase  inhibitors,  a  nonnucleoside  reverse  transcriptase  inhibitor,  a  protease  inhibitor,  and  a  pharmacokinetic  booster.  Since  his  HIV  infection  has  responded  very  well  to  this  drug  regimen,  F.M.’s  physician  is  currently  reluctant  to  switch  to  a  protease  inhibitor-sparing  regimen.  Instead,  she  has  referred  him  to  a  physical  therapist  to  assess  the  efficacy  of  a  nonpharmacological  approach  to  treating  the  hyperglycemia,  dyslipidemia,  and  lipodystrophy.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/18
UR  - accessphysiotherapy.mhmedical.com/content.aspx?aid=1192818297
ER  -